新闻中心

News Center

Home page

All Categories



Company News

Industry News

Top 10 Distributors of Foncoo Pharmaceuticals in Oran visited Dr. Reddy Company in India

Release Time

2022-06-22 10:51

From January 13th to 17th, 2015, Pangu Pharmaceutical organized the top ten distributors in Oran for a 5-day tour of India and a visit to Dr. Reddy's Laboratory Co., Ltd.

During the period, Pangu and his delegation visited the Taj Mahal and Agra Fort, which are one of the seven architectural wonders of the world. They also visited Dr. Reddy's R&D Center, FTO-3 and Biological Products Center. Mr. Ramana, President of Dr. Reddy's Emerging Markets and Mr. Mr.Satheesh, the chief representative of China, accompanied him throughout the journey.

FTO-3 is the production factory of Oranzhi, and it is also the key destination of Pangu’s visit. The factory covers an area of 18 acres, has more than 70 production lines, and has more than 2,000 workers. It passed the CGMP certification of the US FDA in 1998. Passed the certification of MHRA and other countries in the United Kingdom, Pangu and his party visited the whole process from the procurement and transportation of raw and auxiliary materials, preparation synthesis and processing, to sorting and packaging. After the visit, they had firmer confidence in the quality of Oranzhi.

Dr. Reddy's CEO visits Foncoo

The company held the 2014 annual meeting of Oran distributors

Dr. Reddy's CEO visits Foncoo

The company held the 2014 annual meeting of Oran distributors

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

0755-82873500

Room 1502-1506, Building D2, Nanshan iPark, No.1001 Xue Yuan Boulevard, Nanshan District, Shenzhen, China.

0755-82873510

京ICP备10002622号-38

0755-82873500

0755-82873510